|By Marketwired .||
|June 23, 2014 11:11 AM EDT||
SAN DIEGO, CA -- (Marketwired) -- 06/23/14 -- Intellectual dominance in life sciences has traditionally been concentrated in the key markets of Boston, California and Germany, near the multi-national corporations that drive innovation. Yet, a key market ranking -- the third annual JLL Global Life Sciences Cluster Report released today at the BIO International Convention in San Diego -- suggests that the industry may be shifting its intellectual prowess toward emerging markets and middle-market corporate players.
"The biopharmaceutical industry is undergoing a significant transition as start-ups, specialty firms and mid-tier companies become the leading source of new product innovation," said Roger Humphrey, Executive Managing Director of JLL's (NYSE: JLL) Life Sciences group in the Americas. "This shift is reflected in the changing physical landscape of biopharmaceutical operations, including real estate."
The 2014 JLL Global Life Sciences Cluster Report identifies three primary global life sciences trends:
1. Start-ups, specialty firms and mid-tier companies are beginning to lead innovation.
Following the "doom and gloom" era of patent expirations, depleted product pipelines and uncertainty in U.S. healthcare reform, 2013 brought new energy to the life sciences industry. As large pharmaceutical companies continue to retrench, small- to medium-sized companies and specialty players are steadily growing, propelling initial public offerings to a volume not seen since the "dot.com" bubble of the 2000s. In some instances, vacated facilities are being retrofitted to accommodate the growing needs of mid-tier and specialty biopharmaceutical companies seeking space and access to resources.
These trends are stimulating significant changes in biopharmaceutical facilities. In mature markets such as the United States and Western Europe, many large life sciences companies have consolidated their operations and vacated their campuses. In 2013, for example, Germany-based Boehringer Ingelheim put up for sale its 190-acre, world-class production campus in Petersburg, Va., in the southeast United States. The company cited competition from low-cost generic medicines as a factor in the decision.
2. Competition is going global: for innovation, customers and talent.
North America and Europe continue to be the dominant contributors of life sciences Patent Cooperation Treaty (PCT) applications -- but a review of year-over-year application volume by country of origin reveals dramatic global shifts in innovation. Developing countries are beginning to challenge the hegemony of more mature economies.
North America and Europe's PCT life sciences patent volume is steadily decreasing, while that of Asia, Latin America and the Caribbean is increasing. In 2012, China reported the largest year-over-year increase -- 42.8 percent -- in total number of life sciences PCT applications, a rate far outpacing the growth of its overall PCT applications. Asia's share of PCT life sciences applications grew to 26 percent in 2012 from approximately 5 percent in 1990, while North America's share shrank to 41 percent in 2012 from more than 50 percent in 1990.
"Notably, the three countries with the most year-over-year growth in overall PCT applications -- China, Korea and Japan -- are also among the least collaborative countries," notes Erin Bovee, lead researcher for JLL's Global Life Sciences Cluster Report. "These countries appear to be seeking self-sufficiency in innovation."
Emerging countries are also gaining ground in talent development. China educates only a small percentage of its population, yet long ago surpassed the United States as the frontrunner in science and engineering doctorates. The United States remains a leader in awarding higher degrees in science and engineering, but is training fewer young workers than such countries as the Netherlands, South Korea, the United Kingdom, Australia and Japan.
3. Facilities are receiving new attention as a source of cost savings and regulatory compliance.
As detailed in JLL's 2011 Global Life Sciences Cluster Report, global pharmaceutical companies acted quickly in response to the patent cliff by consolidating; reducing their facilities footprints through building sales and decommissioning; trimming labor costs through layoffs; and increasing the outsourcing of non-core services.
"The need for strategic corporate real estate portfolio planning is at an all-time high as companies of all sizes seek operating efficiencies," said Humphrey. "Globally, the changes in life sciences companies' real estate portfolios are some of the most drastic among all industries."
The industry's move to more profitable and faster growth models has led to downsizing in mature markets and a focus on opportunities in emerging markets. JLL's 2014 Global Corporate Real Estate Trends for the Life Sciences Sector found that more than a third of life sciences companies anticipate reducing or consolidating their real estate portfolios in European markets, while 63 percent and 48 percent plan to increase their portfolios in China and Brazil, respectively, and 35 percent in Russia. In 2011, for example, Pfizer opted to relocate its antibacterial research unit from the United States to Shanghai.
Beyond the site selection challenges, many companies have turned to strategic facilities management to reduce operating costs. The life sciences sector is already the most active in facilities outsourcing, according to JLL's Corporate Real Estate Trends report, with 22 percent of companies fully outsourcing portfolio and facilities management functions, compared to 13 percent in other industries.
"Life sciences companies around the world are using qualified service providers to manage not only building systems, but also laboratory and production equipment, hazardous waste, supply chain and other critical areas like facilities regulatory compliance," said Dr. Lee Elliott, Head of EMEA Research for JLL. "We expect facilities outsourcing to continue to extend into highly-regulated spaces that, in the past, were off-limits."
About the Global Life Sciences Cluster Report
JLL's annual Global Life Sciences Cluster Report tracks geographic shifts in life sciences innovation, operations and facilities investments, including a ranking of the top U.S. life sciences clusters and analyses of countries and cities around the world most actively investing in life sciences. The complete findings of the 2014 Global Life Sciences Cluster Report are available here.
About JLL's Life Sciences Capabilities
JLL offers a team of real estate and facility management experts dedicated to helping life sciences companies optimize and manage their real estate portfolios. The firm provides a comprehensive range of services with singular technical operations and GxP expertise dedicated to the Life Sciences and Pharmaceutical community with more than 70 million square feet managed of R&D/pilot plant, manufacturing and office space worldwide. Its industry-leading platform includes Labwell, a comprehensive laboratory service.
A leader in the real estate outsourcing field, JLL's Corporate Solutions business helps corporations improve productivity in the cost, efficiency and performance of their national, regional or global real estate portfolios by creating outsourcing partnerships to manage and execute a range of corporate real estate services. This service delivery capability helps corporations improve business performance, particularly as companies turn to the outsourcing of their real estate activity as a way to manage expenses and enhance profitability.
For more news, videos and research resources on JLL, please visit the firm's global media center Web page http://bit.ly/18P2tkv.
JLL (NYSE: JLL) is a professional services and investment management firm offering specialized real estate services to clients seeking increased value by owning, occupying and investing in real estate. With annual fee revenue of $4 billion, JLL has more than 200 corporate offices and operates in 75 countries worldwide. On behalf of its clients, the firm provides management and real estate outsourcing services for a property portfolio of 3 billion square feet and completed $99 billion in sales, acquisitions and finance transactions in 2013. Its investment management business, LaSalle Investment Management, has $48.0 billion of real estate assets under management. JLL is the brand name of Jones Lang LaSalle Incorporated. For further information, visit www.jll.com.
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2623634
Tintri VM-aware storage is the simplest for virtualized applications and cloud. Organizations including GE, Toyota, United Healthcare, NASA and 6 of the Fortune 15 have said "No to LUNs." With Tintri they manage only virtual machines, in a fraction of the footprint and at far lower cost than conventional storage. Tintri offers the choice of all-flash or hybrid-flash platform, converged or stand-alone structure and any hypervisor. Rather than obsess with storage, leaders focus on the business app...
Feb. 27, 2017 10:15 PM EST Reads: 610
Addteq is one of the top 10 Platinum Atlassian Experts who specialize in DevOps, custom and continuous integration, automation, plugin development, and consulting for midsize and global firms. Addteq firmly believes that automation is essential for successful software releases. Addteq centers its products and services around this fundamentally unique approach to delivering complete software release management solutions. With a combination of Addteq's services and our extensive list of partners,...
Feb. 27, 2017 10:00 PM EST Reads: 1,284
The Internet of Things will challenge the status quo of how IT and development organizations operate. Or will it? Certainly the fog layer of IoT requires special insights about data ontology, security and transactional integrity. But the developmental challenges are the same: People, Process and Platform and how we integrate our thinking to solve complicated problems. In his session at 19th Cloud Expo, Craig Sproule, CEO of Metavine, demonstrated how to move beyond today's coding paradigm and sh...
Feb. 27, 2017 09:15 PM EST Reads: 4,168
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm.
Feb. 27, 2017 08:30 PM EST Reads: 837
Big Data, cloud, analytics, contextual information, wearable tech, sensors, mobility, and WebRTC: together, these advances have created a perfect storm of technologies that are disrupting and transforming classic communications models and ecosystems. In his session at @ThingsExpo, Erik Perotti, Senior Manager of New Ventures on Plantronics’ Innovation team, provided an overview of this technological shift, including associated business and consumer communications impacts, and opportunities it m...
Feb. 27, 2017 08:00 PM EST Reads: 7,958
WebRTC is about the data channel as much as about video and audio conferencing. However, basically all commercial WebRTC applications have been built with a focus on audio and video. The handling of “data” has been limited to text chat and file download – all other data sharing seems to end with screensharing. What is holding back a more intensive use of peer-to-peer data? In her session at @ThingsExpo, Dr Silvia Pfeiffer, WebRTC Applications Team Lead at National ICT Australia, looked at differ...
Feb. 27, 2017 07:45 PM EST Reads: 7,368
For organizations that have amassed large sums of software complexity, taking a microservices approach is the first step toward DevOps and continuous improvement / development. Integrating system-level analysis with microservices makes it easier to change and add functionality to applications at any time without the increase of risk. Before you start big transformation projects or a cloud migration, make sure these changes won’t take down your entire organization.
Feb. 27, 2017 07:45 PM EST Reads: 1,609
With major technology companies and startups seriously embracing IoT strategies, now is the perfect time to attend @ThingsExpo 2016 in New York. Learn what is going on, contribute to the discussions, and ensure that your enterprise is as "IoT-Ready" as it can be! Internet of @ThingsExpo, taking place June 6-8, 2017, at the Javits Center in New York City, New York, is co-located with 20th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry p...
Feb. 27, 2017 07:30 PM EST Reads: 2,255
SYS-CON Events announced today that IoT Now has been named “Media Sponsor” of SYS-CON's 20th International Cloud Expo, which will take place on June 6–8, 2017, at the Javits Center in New York City, NY. IoT Now explores the evolving opportunities and challenges facing CSPs, and it passes on some lessons learned from those who have taken the first steps in next-gen IoT services.
Feb. 27, 2017 07:15 PM EST Reads: 1,972
The Internet of Things can drive efficiency for airlines and airports. In their session at @ThingsExpo, Shyam Varan Nath, Principal Architect with GE, and Sudip Majumder, senior director of development at Oracle, discussed the technical details of the connected airline baggage and related social media solutions. These IoT applications will enhance travelers' journey experience and drive efficiency for the airlines and the airports.
Feb. 27, 2017 07:00 PM EST Reads: 2,600
SYS-CON Events announced today that WineSOFT will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Based in Seoul and Irvine, WineSOFT is an innovative software house focusing on internet infrastructure solutions. The venture started as a bootstrap start-up in 2010 by focusing on making the internet faster and more powerful. WineSOFT’s knowledge is based on the expertise of TCP/IP, VPN, SSL, peer-to-peer, mob...
Feb. 27, 2017 07:00 PM EST Reads: 2,199
DevOps is being widely accepted (if not fully adopted) as essential in enterprise IT. But as Enterprise DevOps gains maturity, expands scope, and increases velocity, the need for data-driven decisions across teams becomes more acute. DevOps teams in any modern business must wrangle the ‘digital exhaust’ from the delivery toolchain, "pervasive" and "cognitive" computing, APIs and services, mobile devices and applications, the Internet of Things, and now even blockchain.
Feb. 27, 2017 06:45 PM EST Reads: 2,252
A strange thing is happening along the way to the Internet of Things, namely far too many devices to work with and manage. It has become clear that we'll need much higher efficiency user experiences that can allow us to more easily and scalably work with the thousands of devices that will soon be in each of our lives. Enter the conversational interface revolution, combining bots we can literally talk with, gesture to, and even direct with our thoughts, with embedded artificial intelligence, whic...
Feb. 27, 2017 06:30 PM EST Reads: 2,134
Have you ever noticed how some IT people seem to lead successful, rewarding, and satisfying lives and careers, while others struggle? IT author and speaker Don Crawley uncovered the five principles that successful IT people use to build satisfying lives and careers and he shares them in this fast-paced, thought-provoking webinar. You'll learn the importance of striking a balance with technical skills and people skills, challenge your pre-existing ideas about IT customer service, and gain new in...
Feb. 27, 2017 06:15 PM EST Reads: 516
WebRTC sits at the intersection between VoIP and the Web. As such, it poses some interesting challenges for those developing services on top of it, but also for those who need to test and monitor these services. In his session at WebRTC Summit, Tsahi Levent-Levi, co-founder of testRTC, reviewed the various challenges posed by WebRTC when it comes to testing and monitoring and on ways to overcome them.
Feb. 27, 2017 06:15 PM EST Reads: 8,312